Copyright Reports & Markets. All rights reserved.

Global Asthma Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Asthma Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Breathing Exercises
      • 1.4.3 Rescue/First Aid Treatments
      • 1.4.4 Long-Term Asthma Control Medications
      • 1.4.5 Monoclonal Antibody
    • 1.5 Market by Application
      • 1.5.1 Global Asthma Treatment Market Share by Application (2014-2025)
      • 1.5.2 Mild Intermittent
      • 1.5.3 Mild Persistent
      • 1.5.4 Moderate Persistent
      • 1.5.5 Severe Persistent
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Asthma Treatment Market Size
    • 2.2 Asthma Treatment Growth Trends by Regions
      • 2.2.1 Asthma Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Asthma Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Asthma Treatment Market Size by Manufacturers
      • 3.1.1 Global Asthma Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Asthma Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Asthma Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Asthma Treatment Key Players Head office and Area Served
    • 3.3 Key Players Asthma Treatment Product/Solution/Service
    • 3.4 Date of Enter into Asthma Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Asthma Treatment Market Size by Type (2014-2019)
    • 4.2 Global Asthma Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Asthma Treatment Market Size (2014-2019)
    • 5.2 Asthma Treatment Key Players in United States
    • 5.3 United States Asthma Treatment Market Size by Type
    • 5.4 United States Asthma Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Asthma Treatment Market Size (2014-2019)
    • 6.2 Asthma Treatment Key Players in Europe
    • 6.3 Europe Asthma Treatment Market Size by Type
    • 6.4 Europe Asthma Treatment Market Size by Application

    7 China

    • 7.1 China Asthma Treatment Market Size (2014-2019)
    • 7.2 Asthma Treatment Key Players in China
    • 7.3 China Asthma Treatment Market Size by Type
    • 7.4 China Asthma Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Asthma Treatment Market Size (2014-2019)
    • 8.2 Asthma Treatment Key Players in Japan
    • 8.3 Japan Asthma Treatment Market Size by Type
    • 8.4 Japan Asthma Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Asthma Treatment Market Size (2014-2019)
    • 9.2 Asthma Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Asthma Treatment Market Size by Type
    • 9.4 Southeast Asia Asthma Treatment Market Size by Application

    10 India

    • 10.1 India Asthma Treatment Market Size (2014-2019)
    • 10.2 Asthma Treatment Key Players in India
    • 10.3 India Asthma Treatment Market Size by Type
    • 10.4 India Asthma Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Asthma Treatment Market Size (2014-2019)
    • 11.2 Asthma Treatment Key Players in Central & South America
    • 11.3 Central & South America Asthma Treatment Market Size by Type
    • 11.4 Central & South America Asthma Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 AstraZeneca
      • 12.1.1 AstraZeneca Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Asthma Treatment Introduction
      • 12.1.4 AstraZeneca Revenue in Asthma Treatment Business (2014-2019)
      • 12.1.5 AstraZeneca Recent Development
    • 12.2 GSK
      • 12.2.1 GSK Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Asthma Treatment Introduction
      • 12.2.4 GSK Revenue in Asthma Treatment Business (2014-2019)
      • 12.2.5 GSK Recent Development
    • 12.3 Novartis
      • 12.3.1 Novartis Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Asthma Treatment Introduction
      • 12.3.4 Novartis Revenue in Asthma Treatment Business (2014-2019)
      • 12.3.5 Novartis Recent Development
    • 12.4 Boehringer Ingelheim
      • 12.4.1 Boehringer Ingelheim Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Asthma Treatment Introduction
      • 12.4.4 Boehringer Ingelheim Revenue in Asthma Treatment Business (2014-2019)
      • 12.4.5 Boehringer Ingelheim Recent Development
    • 12.5 Merck & Co. Inc
      • 12.5.1 Merck & Co. Inc Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Asthma Treatment Introduction
      • 12.5.4 Merck & Co. Inc Revenue in Asthma Treatment Business (2014-2019)
      • 12.5.5 Merck & Co. Inc Recent Development
    • 12.6 Roche Holdings Ltd
      • 12.6.1 Roche Holdings Ltd Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Asthma Treatment Introduction
      • 12.6.4 Roche Holdings Ltd Revenue in Asthma Treatment Business (2014-2019)
      • 12.6.5 Roche Holdings Ltd Recent Development
    • 12.7 Sunovion Pharmaceuticals Inc
      • 12.7.1 Sunovion Pharmaceuticals Inc Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Asthma Treatment Introduction
      • 12.7.4 Sunovion Pharmaceuticals Inc Revenue in Asthma Treatment Business (2014-2019)
      • 12.7.5 Sunovion Pharmaceuticals Inc Recent Development
    • 12.8 Schering-Plough Corp
      • 12.8.1 Schering-Plough Corp Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Asthma Treatment Introduction
      • 12.8.4 Schering-Plough Corp Revenue in Asthma Treatment Business (2014-2019)
      • 12.8.5 Schering-Plough Corp Recent Development
    • 12.9 Sanofi
      • 12.9.1 Sanofi Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Asthma Treatment Introduction
      • 12.9.4 Sanofi Revenue in Asthma Treatment Business (2014-2019)
      • 12.9.5 Sanofi Recent Development
    • 12.10 Theravance Inc
      • 12.10.1 Theravance Inc Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Asthma Treatment Introduction
      • 12.10.4 Theravance Inc Revenue in Asthma Treatment Business (2014-2019)
      • 12.10.5 Theravance Inc Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Asthma is an inflammatory disease of the airways to the lungs. It makes breathing difficult and can make some physical activities difficult or even impossible.
      Treatments for asthma fall into three primary categories: breathing exercises, rescue or first aid treatments, and long-term asthma control medications.

      In 2018, the global Asthma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Asthma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Asthma Treatment development in United States, Europe and China.

      The key players covered in this study
      AstraZeneca
      GSK
      Novartis
      Boehringer Ingelheim
      Merck & Co. Inc
      Roche Holdings Ltd
      Sunovion Pharmaceuticals Inc
      Schering-Plough Corp
      Sanofi
      Theravance Inc

      Market segment by Type, the product can be split into
      Breathing Exercises
      Rescue/First Aid Treatments
      Long-Term Asthma Control Medications
      Monoclonal Antibody

      Market segment by Application, split into
      Mild Intermittent
      Mild Persistent
      Moderate Persistent
      Severe Persistent

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Asthma Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Asthma Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Asthma Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now